Cargando…

Nobiletin Attenuates VLDL Overproduction, Dyslipidemia, and Atherosclerosis in Mice With Diet-Induced Insulin Resistance

OBJECTIVE: Increased plasma concentrations of apolipoprotein B100 often present in patients with insulin resistance and confer increased risk for the development of atherosclerosis. Naturally occurring polyphenolic compounds including flavonoids have antiatherogenic properties. The aim of the curren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulvihill, Erin E., Assini, Julia M., Lee, Justin K., Allister, Emma M., Sutherland, Brian G., Koppes, Julie B., Sawyez, Cynthia G., Edwards, Jane Y., Telford, Dawn E., Charbonneau, Alexandre, St-Pierre, Philippe, Marette, André, Huff, Murray W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292317/ https://www.ncbi.nlm.nih.gov/pubmed/21471511 http://dx.doi.org/10.2337/db10-0589

Ejemplares similares

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance
por: Mulvihill, Erin E., et al.
Publicado: (2009)

Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol
por: Shojaee-Moradie, Fariba, et al.
Publicado: (2013)

Apolipoprotein E4 Exaggerates Diabetic Dyslipidemia and Atherosclerosis in Mice Lacking the LDL Receptor
por: Johnson, Lance A., et al.
Publicado: (2011)

Similar VLDL-TG Storage in Visceral and Subcutaneous Fat in Obese and Lean Women
por: Søndergaard, Esben, et al.
Publicado: (2011)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Femoral Adipose Tissue May Accumulate the Fat That Has Been Recycled as VLDL and Nonesterified Fatty Acids
por: McQuaid, Siobhán E., et al.
Publicado: (2010)

Increased VLDL-Triglyceride Secretion Precedes Impaired Control of Endogenous Glucose Production in Obese, Normoglycemic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
por: Bruinstroop, Eveline, et al.
Publicado: (2012)

GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance
por: Taher, Jennifer, et al.
Publicado: (2014)

Long Noncoding RNA lncRHL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis
por: Shen, Xuan, et al.
Publicado: (2022)

Hepatocyte-Specific Ptpn6 Deletion Protects From Obesity-Linked Hepatic Insulin Resistance
por: Xu, Elaine, et al.
Publicado: (2012)

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome
por: Ooi, Esther M.M., et al.
Publicado: (2008)

PMON31 IL-4 Serum Levels Correlate with Triglycerides and VLDL in African American males
por: Johnson, Abraham, et al.
Publicado: (2022)

Long-term Stress with Hyperglucocorticoidemia-induced Hepatic Steatosis with VLDL Overproduction Is Dependent on both 5-HT2 Receptor and 5-HT Synthesis in Liver
por: Fu, Jihua, et al.
Publicado: (2016)

Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation
por: Mulvihill, Erin E., et al.
Publicado: (2012)

VLDL-associated mutagenic activity.
por: Gomes, M. I., et al.
Publicado: (1982)

Dyslipidemia and Obesity in Ischemic Stroke
por: Gajurel, Bikram P, et al.
Publicado: (2023)

Atherosclerosis-associated hepatic secretion of VLDL but not PCSK9 is dependent on cargo receptor protein Surf4
por: Wang, Bingxiang, et al.
Publicado: (2021)

Bariatric surgery improves postprandial VLDL kinetics and restores insulin-mediated regulation of hepatic VLDL production
por: Yildirim, Vehpi, et al.
Publicado: (2023)

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
por: Bage, Isaac J, et al.
Publicado: (2023)

Obese Mice Lacking Inducible Nitric Oxide Synthase Are Sensitized to the Metabolic Actions of Peroxisome Proliferator–Activated Receptor-γ Agonism
por: Dallaire, Patrice, et al.
Publicado: (2008)

Effect of Nobiletin on Experimental Model of Epilepsy
por: Yang, Baowang, et al.
Publicado: (2018)

Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion
por: van Zwol, Willemien, et al.
Publicado: (2023)

Unraveling the role of VLDL in the relationship between type 2 diabetes and coronary atherosclerosis: a Mendelian randomization analysis
por: Feng, Wenshuai, et al.
Publicado: (2023)

Zebrafish Models for Dyslipidemia and Atherosclerosis Research
por: Schlegel, Amnon
Publicado: (2016)

An Overproduction of Scholars
Publicado: (1893)

Obesity, Dyslipidemia, Diabetes, and Vitamin D Levels
por: Moya, Elena A Amoroso, et al.
Publicado: (2021)

Triglyceride Rich Lipoprotein -LPL-VLDL Receptor and Lp(a)-VLDL Receptor Pathways for Macrophage Foam Cell Formation
por: Takahashi, Sadao
Publicado: (2017)

Myeloid Deletion of α1AMPK Exacerbates Atherosclerosis in LDL Receptor Knockout (LDLRKO) Mice
por: Cao, Qiang, et al.
Publicado: (2016)

Pharmacological actions of nobiletin in the modulation of platelet function
por: Vaiyapuri, Sakthivel, et al.
Publicado: (2015)

Transdermal delivery of nobiletin using ionic liquids
por: Hattori, Tadashi, et al.
Publicado: (2019)

ABCC6 deficiency promotes dyslipidemia and atherosclerosis
por: Brampton, Christopher, et al.
Publicado: (2021)

Mathematical modelling of competitive LDL/VLDL binding and uptake by hepatocytes
por: Pearson, T., et al.
Publicado: (2008)

Effects of Electronegative VLDL on Endothelium Damage in Metabolic Syndrome
por: Chen, Chu-Huang, et al.
Publicado: (2012)

VLDL receptor gene therapy for reducing atherogenic lipoproteins
por: Krauss, Ronald M., et al.
Publicado: (2023)

The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro
por: Huang, Hao, et al.
Publicado: (2016)

Inducible Nitric Oxide Synthase Induction Underlies Lipid-Induced Hepatic Insulin Resistance in Mice: Potential Role of Tyrosine Nitration of Insulin Signaling Proteins
por: Charbonneau, Alexandre, et al.
Publicado: (2010)

Carotenoid biosynthesis and overproduction in Corynebacterium glutamicum
por: Heider, Sabine A E, et al.
Publicado: (2012)

New insight into dyslipidemia‐induced cellular senescence in atherosclerosis
por: Xiang, Qunyan, et al.
Publicado: (2022)

Apolipoprotein E content of VLDL limits LPL-mediated triglyceride hydrolysis
por: Whitacre, Brynne E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oqd9df94r5r6fem35rkj1i53d8